October 15, 2019

Boustead Securities, LLC, IPO client Soliton, Inc. (NASDAQ: SOLY), a medical device company with a new and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), completed definitive agreements...

July 23, 2019

Boustead Securities, LLC, IPO client Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a new and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), an...

Please reload

Recent Posts
  • Boustead Securities LinkedIn
  • Facebook Basic Square
Please reload

Archive
Please reload

Search By Tags